Home688062 • SHA
add
Mabwell Shanghai Bioscience Co Ltd
Previous close
¥35.37
Day range
¥35.20 - ¥36.99
Year range
¥19.44 - ¥37.00
Market cap
14.13B CNY
Avg Volume
2.33M
P/E ratio
-
Dividend yield
-
Primary exchange
SHA
Market news
BAC
1.00%
1.26%
Financials
Income Statement
Revenue
Net income
(CNY) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 67.56M | 1,572.42% |
Operating expense | 266.56M | 5.32% |
Net income | -205.66M | 14.70% |
Net profit margin | -304.43 | 94.90% |
Earnings per share | — | — |
EBITDA | -185.27M | 21.77% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.80B | -21.94% |
Total assets | 4.64B | -0.25% |
Total liabilities | 2.25B | 65.97% |
Total equity | 2.40B | — |
Shares outstanding | 403.25M | — |
Price to book | 5.92 | — |
Return on assets | -10.99% | — |
Return on capital | -12.25% | — |
Cash Flow
Net change in cash
(CNY) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -205.66M | 14.70% |
Cash from operations | -330.60M | -116.54% |
Cash from investing | -175.79M | 31.00% |
Cash from financing | 584.44M | 243.22% |
Net change in cash | 78.07M | 132.77% |
Free cash flow | -540.20M | -49.92% |
About
Founded
May 12, 2017
Website
Employees
1,491